Emdeon announces co-pay assistance program
NASHVILLE, Tenn. — Emdeon on Monday announced the launch of Emdeon Easy Save for retail pharmacies. The program gives access to some of the largest copay assistance programs available also while encouraging retail pharmacies to offer copay coupon programs to customers when they need it, according to the company.
"We know from industry research that lower out-of-pocket patient costs can lead to higher medication compliance, and that in turn, higher medication compliance typically leads to better health outcomes," said Kevin Mahoney, EVP of pharmacy services for Emdeon. "We are proud to deliver a simplified copay coupon assistance program to the pharmacies we serve as they strive to increase medication compliance and reduce patients' costs."
Emdeon partnered with PSKW, a provider of biopharma loyalty relationship marketing services, to deliver the program. PSKW helps identify the best available offer for copay assistance. Results from Emdeon Easy Save data have shown that patients refill their prescriptions with more frequency — two to three more prescription refills per year — and stay on therapy longer than patients who are not offered copay assistance programs, the company said.
"With so many competing economic priorities out there for patients, we are pleased to work with Emdeon to provide a straightforward solution that maximizes PSKW's broad pharma relationships and pairs that with Emdeon's vast reach into the retail pharmacy," said Robert Previdi, chairman and CEO of PSKW.
H-E-B, Thrifty White recognized for political involvement at NACDS TSE
BOSTON — H-E-B and Thrify White Pharmacy were recognized for their political advocacy and grassroots support at the National Association of Chain Drug Stores Political Involvement Reception during the NACDS Total Store Expo in Boston.
NACDS chain member H-E-B received the NACDS RxImpact “Leader of the Year” award for its engagement in numerous NACDS RxImpact events. Thrifty White Pharamcy was honored with the NACDS Political Action Committee “Politically Engaged Pharmacy” award in recognition of exceptional commitment to advancing pharmacy through the NACDS-PAC.
“Political and grassroots involvement is so vital for pharmacy to succeed in public policy,” NACDS president and CEO Steven Anderson, IOM, CAE stated. “We congratulate H-E-B and Thrifty White for their commitment to the NACDS RxImpact program and the NACDS-PAC. Everything we do on behalf of the chain pharmacy industry is done to reinforce our theme of pharmacy being the face of neighborhood healthcare, and these two companies do so much to convey that important message.”
The NACDS RxImpact grassroots program was launched to further advance pro-patient, pro-pharmacy policies. The program’s many facets — including the NACDS RxImpact Day on Capitol Hill meetings with policymakers in Washington and NACDS RxImpact pharmacy tours bringing members of Congress into pharmacies in their states and districts — are just some of the opportunities to help engage policymakers about the value of pharmacy in improving healthcare delivery, NACDS stated.
Nipro Diagnostics gets FDA approval for blood-glucose monitors
FORT LAUDERDALE, Fla. — Nipro Diagnostics announced that the Food and Drug Administration approved its True Metrix self-monitoring blood-glucose system, as well as the True Metrix Pro professional monitoring blood-glucose system. The company made the announcement at the National Association of Chain Drug Stores Total Store Expo in Boston.
The meters use pre- and post-meal tags that allow patients to mark results to help better understand how food affects blood glucose. Patients also are able to tie noteworthy events — exercise, medication, sickness and other occasions — to blood glucose readings to determine patterns and trends, helping them to make better decisions in the management of diabetes, the company said.
“It is essential as the store brand leader in diabetes that we continue to innovate from both a technology and a business perspective. The evolving payer landscape, driven by demands of increased clinical performance and economic accountability, has created a market energized in disruption. The True Metrix blood glucose monitoring platform reinforces our commitment to offer an innovative, affordable solution for diabetes patients to lead healthier lives,” Scott Verner, CEO and president of Nipro Diagnostics, said.
True Metrix will be available through retail, mail and distribution channels beginning fourth-quarter 2014.